Impact on Survival and Toxicity by Duration of Weight Extremes During Treatment for Pediatric Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group
Etan Orgel(Children's Hospital of Los Angeles), David R. Freyer(University of Southern California), Elena D Ladas(University of Southern California), Nita L. Seibel(National Cancer Institute), Jemily Malvar(University of Southern California), Richard Sposto(Children's Hospital of Los Angeles), Paul S. Gaynon(University of Southern California)
Cited by 191
Related Papers
Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia
|New England Journal of Medicine|1999|1.2k
Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia.
|Journal of Clinical Oncology|1996|914
Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study
|Leukemia|2008|581
Randomized Study of Two Chemotherapy Regimens for Treatment of Low-Grade Glioma in Young Children: A Report From the Children's Oncology Group
|Journal of Clinical Oncology|2012|433